AA
ASMB icon

ALPS Advisors’s Assembly Biosciences ASMB Stock Holding History

ALPS Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,979
Closed -$275K – 905
2021
Q1 		$275K Buy
4,979
+77
+2% +$5.1K ﹤0.01% 838
2020
Q4 		$356K Buy
4,902
+1,410
+40% +$165K ﹤0.01% 595
2020
Q3 		$689K Sell
3,492
-228
-6% -$57.4K 0.01% 389
2020
Q2 		$1.04M Sell
3,720
-980
-21% -$229K 0.01% 310
2020
Q1 		$836K Buy
4,700
+294
+7% +$63K 0.01% 312
2019
Q4 		$1.08M Buy
4,406
+135
+3% +$24.9K 0.01% 330
2019
Q3 		$504K Sell
4,271
-185
-4% -$28K ﹤0.01% 499
2019
Q2 		$721K Buy
+4,456
New +$847K 0.01% 424
2018
Q4 		– Sell
-3,753
Closed -$1.67M – 881
2018
Q3 		$1.67M Buy
3,753
+1,268
+51% +$594K 0.01% 273
2018
Q2 		$1.17M Buy
+2,485
New +$1.31M 0.01% 302

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

ALPS Advisors's ASMB Position: Q2 2021 in Review

ALPS Advisors sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 4,979 shares — an estimated $275K sold.

ALPS Advisors first reported a position in ASMB in Q2 2018 and held it in 10 quarters. The position peaked at $1.67M in Q3 2018. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • ALPS Advisors reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • ALPS Advisors sold 4,979 Assembly Biosciences shares in Q2 2021, an estimated $275K.
  • ALPS Advisors first reported a position in Assembly Biosciences in Q2 2018 and held it in 10 quarters.
  • ALPS Advisors's Assembly Biosciences position peaked at $1.67M in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on ALPS Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.